BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38617536)

  • 1. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21
    Ren G; Chen J; Pu Y; Yang EJ; Tao S; Mou PK; Chen LJ; Zhu W; Chan KL; Luo G; Deng C; Shim JS
    Int J Biol Sci; 2024; 20(6):1978-1991. PubMed ID: 38617536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression.
    Shi C; Yang EJ; Liu Y; Mou PK; Ren G; Shim JS
    Oncogene; 2021 Feb; 40(5):937-950. PubMed ID: 33293694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
    Wu T; Wang G; Chen W; Zhu Z; Liu Y; Huang Z; Huang Y; Du P; Yang Y; Liu CY; Cui L
    Cell Death Dis; 2018 Feb; 9(3):315. PubMed ID: 29472532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT.
    Liu Y; Yang EJ; Shi C; Mou PK; Zhang B; Wu C; Lyu J; Shim JS
    Int J Biol Sci; 2020; 16(11):1774-1784. PubMed ID: 32398948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism.
    Ren G; Yang EJ; Tao S; Mou PK; Pu Y; Chen LJ; Shim JS
    Int J Biol Sci; 2023; 19(11):3544-3557. PubMed ID: 37496993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of c-Myc enhances p21
    Jeong YJ; Hoe HS; Cho HJ; Park KK; Kim DD; Kim CH; Magae J; Kang DW; Lee SR; Chang YC
    J Cell Biochem; 2018 Feb; 119(2):2036-2047. PubMed ID: 28833404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells.
    Kalimutho M; Minutolo A; Grelli S; Federici G; Bernardini S
    Acta Pharmacol Sin; 2011 Nov; 32(11):1387-96. PubMed ID: 21927014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bergapten induces G1 arrest and pro-apoptotic cascade in colorectal cancer cells associating with p53/p21/PTEN axis.
    Lin CP; Lin CS; Lin HH; Li KT; Kao SH; Tsao SM
    Environ Toxicol; 2019 Mar; 34(3):303-311. PubMed ID: 30576070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Lethality in PTEN-Mutant Prostate Cancer Is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition.
    Ren W; Joshi R; Mathew P
    Mol Cancer Res; 2016 Dec; 14(12):1176-1181. PubMed ID: 27590631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.
    Zheng T; Meng X; Wang J; Chen X; Yin D; Liang Y; Song X; Pan S; Jiang H; Liu L
    J Cell Biochem; 2010 Sep; 111(1):218-28. PubMed ID: 20506484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
    Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
    J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A.
    Liu Y; Yang EJ; Zhang B; Miao Z; Wu C; Lyu J; Tan K; Poon TCW; Shim JS
    Cancer Lett; 2018 Nov; 436():28-37. PubMed ID: 30118842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21(WAF1/Cip1) and PTEN/AKT pathway.
    Kim EJ; Lee SY; Kim TR; Choi SI; Cho EW; Kim KC; Kim IG
    Biochem Biophys Res Commun; 2010 Feb; 392(3):448-53. PubMed ID: 20079711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
    Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
    Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation.
    Shi C; Tao S; Ren G; Yang EJ; Shu X; Mou PK; Liu Y; Dang Y; Xu X; Shim JS
    Oncogene; 2022 May; 41(19):2734-2748. PubMed ID: 35393542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.
    Liu H; Wang J; Tao Y; Li X; Qin J; Bai Z; Chi B; Yan W; Chen X
    Life Sci; 2019 Mar; 221():354-361. PubMed ID: 30811964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.
    Tögel L; Nightingale R; Chueh AC; Jayachandran A; Tran H; Phesse T; Wu R; Sieber OM; Arango D; Dhillon AS; Dawson MA; Diez-Dacal B; Gahman TC; Filippakopoulos P; Shiau AK; Mariadason JM
    Mol Cancer Ther; 2016 Jun; 15(6):1217-26. PubMed ID: 26983878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.